781 related articles for article (PubMed ID: 17206612)
21. The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists.
Birnkammer T; Spickenreither A; Brunskole I; Lopuch M; Kagermeier N; Bernhardt G; Dove S; Seifert R; Elz S; Buschauer A
J Med Chem; 2012 Feb; 55(3):1147-60. PubMed ID: 22216892
[TBL] [Abstract][Full Text] [Related]
22. Characterization of histamine H2-receptors in human neutrophils with a series of guanidine analogues of impromidine. Are cell type-specific H2-receptors involved in the regulation of NADPH oxidase?
Burde R; Buschauer A; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):455-61. PubMed ID: 1694972
[TBL] [Abstract][Full Text] [Related]
23. Influence of the N-terminus and the E2-loop onto the binding kinetics of the antagonist mepyramine and the partial agonist phenoprodifen to H(1)R.
Wittmann HJ; Seifert R; Strasser A
Biochem Pharmacol; 2011 Dec; 82(12):1910-8. PubMed ID: 21933664
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
Igel P; Geyer R; Strasser A; Dove S; Seifert R; Buschauer A
J Med Chem; 2009 Oct; 52(20):6297-313. PubMed ID: 19791743
[TBL] [Abstract][Full Text] [Related]
25. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
Sadek B; Elz S; Pertz HH; Stark H; Schunack W
Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
[TBL] [Abstract][Full Text] [Related]
26. [Impromidine-analogous guanidines: synthesis and activity at the histamine H2-receptor. 29. Histamine analogs].
Elz S; Schunack W
Arzneimittelforschung; 1988 Mar; 38(3):327-32. PubMed ID: 2898245
[TBL] [Abstract][Full Text] [Related]
27. Effects of impromidine, a specific H2-receptor agonist and 2(2-pyridyl)-ethylamine, an H1-receptor agonist, on stimulation-induced release of [3H]-noradrenaline in guinea-pig isolated atria.
Rand MJ; Story DF; Wong-Dusting H
Br J Pharmacol; 1982 Jun; 76(2):305-11. PubMed ID: 6212093
[TBL] [Abstract][Full Text] [Related]
28. [H2-antagonistic activity of the impromidine analog, cyanoguanidine. 37. H2 antihistaminics].
Elz S; Schunack W
Arzneimittelforschung; 1988 Jan; 38(1):7-10. PubMed ID: 2896510
[TBL] [Abstract][Full Text] [Related]
29. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.
Menghin S; Pertz HH; Kramer K; Seifert R; Schunack W; Elz S
J Med Chem; 2003 Dec; 46(25):5458-70. PubMed ID: 14640554
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological differences between human and guinea pig histamine H1 receptors: Asn84 (2.61) as key residue within an additional binding pocket in the H1 receptor.
Bruysters M; Jongejan A; Gillard M; van de Manakker F; Bakker RA; Chatelain P; Leurs R
Mol Pharmacol; 2005 Apr; 67(4):1045-52. PubMed ID: 15626750
[TBL] [Abstract][Full Text] [Related]
31. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
Schneider EH; Strasser A; Thurmond RL; Seifert R
J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
[TBL] [Abstract][Full Text] [Related]
32. Dimeric carbamoylguanidine-type histamine H2 receptor ligands: A new class of potent and selective agonists.
Kagermeier N; Werner K; Keller M; Baumeister P; Bernhardt G; Seifert R; Buschauer A
Bioorg Med Chem; 2015 Jul; 23(14):3957-69. PubMed ID: 25639885
[TBL] [Abstract][Full Text] [Related]
33. The pharmacological activity of some new fluorescent small molecule histamine H2 receptor (H2-R) ligands, derived from aminopotentidine and squaramide, in the GTPase assay.
Petrache G; Pavelescu MD
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):255-9. PubMed ID: 20509312
[TBL] [Abstract][Full Text] [Related]
34. Histamine H1 receptors mediate vasodilation in guinea-pig ileum resistance vessels: characterization with computer-assisted videomicroscopy and new selective agonists.
Bungardt E; Buschauer A; Moser U; Schunack W; Lambrecht G; Mutschler E
Eur J Pharmacol; 1992 Oct; 221(1):91-8. PubMed ID: 1459193
[TBL] [Abstract][Full Text] [Related]
35. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
[TBL] [Abstract][Full Text] [Related]
36. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
37. Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor.
Wittmann HJ; Seifert R; Strasser A
Mol Pharmacol; 2009 Jul; 76(1):25-37. PubMed ID: 19346300
[TBL] [Abstract][Full Text] [Related]
38. Cerebral circulation and histamine: 2. Responses of pial veins and arterioles to receptor agonists.
Gross PM; Harper AM; Teasdale GM
J Cereb Blood Flow Metab; 1981; 1(2):219-25. PubMed ID: 6460043
[TBL] [Abstract][Full Text] [Related]
39. The determination of receptor constants for histamine H2-agonists in the guinea-pig isolated right atrium using an irreversible H2-antagonist.
Rising TJ; Steward A
Br J Pharmacol; 1986 Jan; 87(1):211-6. PubMed ID: 2869811
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine.
Xie SX; Petrache G; Schneider E; Ye QZ; Bernhardt G; Seifert R; Buschauer A
Bioorg Med Chem Lett; 2006 Aug; 16(15):3886-90. PubMed ID: 16730977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
